Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. (MNLO) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 95 transactions totaling $25.0M, demonstrating a bullish sentiment with $17.4M in net insider flow. The most recent transaction on Aug 20, 2020 involved a transaction of 75,000 shares valued at $111.0K.
MNLO Insider Activity Summary
Who Is Buying MNLO Stock?
No significant insider buying has been recorded for MNLO in the recent period.
Who Is Selling MNLO Stock?
No significant insider selling has been recorded for MNLO in the recent period.
Is Menlo Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MNLO is bullish with an Insider Alignment Score of 85/100 and a net flow of $17.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MNLO Frequently Asked Questions
Understanding MNLO Insider Activity
Insider trading at Menlo Therapeutics, Inc. (MNLO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading MNLO stock, having executed 95 transactions in the past 90 days. The most active insider is Albert Cha (Executive), who has made 6 transactions totaling $5.0M.
Related Tools
Track Menlo Therapeutics, Inc. Insider Activity
Get notified when executives and directors at MNLO file new Form 4 transactions